The Federal Drug Administration (FDA) has approved a new once-daily weight-loss pill from Eli Lilly, adding to the bevy of GLP-1 medications available in the consumer marketplace. The drug manufacturer announced on Tuesday that the company would begin shipping orforglipron, branded as Foundayo, as soon as Monday following approval from federal regulators. Prescribed as a…
FDA grants speedy approval to Eli Lilly weight-loss pill
Originally reported by The Hill
Related Articles
NATO’s Rutte schedules Washington trip as Trump reevaluates alliance
NATO Secretary General Mark Rutte will meet with President Trump in Washington next week as Trump publicly weighs pullin...
Trump Has Discussed Firing Attorney General Pam Bondi
President Trump has not made a final decision, but he has floated the idea of replacing Ms. Bondi with Lee Zeldin, the E...
Iranian president leaves door open to diplomacy in open letter to US
Iranian President Masoud Pezeshkian released a letter addressed to “the people of the United States of America” on Wedne...
FDA’s Makary touts ‘healing’ following DOGE cuts
Click in for more news from The Hill {beacon} Health Care Health Care   The Big Story  FDA commissioner credi...